Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Positive Airway Pressure to Enhance Computed Tomography Imaging for Airway Segmentation for Virtual Bronchoscopic Navigation.

Diez-Ferrer M, Gil D, Tebe C, Sanchez C, Cubero N, López-Lisbona R, Dorca J, Rosell A; on behalf of the PAP-enhanced CT study group.

Respiration. 2018 Sep 18:1-10. doi: 10.1159/000490915. [Epub ahead of print]

PMID:
30227414
2.

Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients.

Máiz L, Girón RM, Prats E, Clemente MG, Polverino E, Caño S, Cordovilla R, Dorca J, Peñalver C, Baranda F, Martínez-García MA.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618787385. doi: 10.1177/1753466618787385.

3.

Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient.

Rodríguez-Jiménez P, Mir-Viladrich I, Chicharro P, Solano-López G, López-Longo FJ, Taxonera C, Sánchez-Martínez P, Martínez-Lacasa X, García-Gasalla M, Dorca J, Arias-Guillén M, García-García JM, Dauden E.

Actas Dermosifiliogr. 2018 Sep;109(7):584-601. doi: 10.1016/j.ad.2018.03.013. Epub 2018 Jun 2. English, Spanish.

PMID:
29871738
4.

Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.

Aliagas E, Muñoz-Esquerre M, Cuevas E, Careta O, Huertas D, López-Sánchez M, Escobar I, Dorca J, Santos S.

Respir Res. 2018 May 28;19(1):103. doi: 10.1186/s12931-018-0793-0.

5.

Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014.

Santin M, Barrabeig I, Malchair P, Gonzalez-Luquero L, Benitez MA, Sabria J, Palau-Benavent M, Cañete C, Lloret-Queraltó JA, Grijota-Camino MD, Dorca J, Alcaide F.

Emerg Infect Dis. 2018 Jun;24(6):1091-1094. doi: 10.3201/eid2406.172095.

6.

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.

Molina-Molina M, Machahua-Huamani C, Vicens-Zygmunt V, Llatjós R, Escobar I, Sala-Llinas E, Luburich-Hernaiz P, Dorca J, Montes-Worboys A.

BMC Pulm Med. 2018 Apr 27;18(1):63. doi: 10.1186/s12890-018-0626-4.

7.

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients.

Muñoz-Esquerre M, Ferreiro JL, Huertas D, Marcano AL, López-Sánchez M, Roura G, Gómez-Hospital JA, Dorca J, Cequier A, Santos S.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 28;13:141-148. doi: 10.2147/COPD.S152660. eCollection 2018.

8.

Specific IgA against Pseudomonas aeruginosa in severe COPD.

Millares L, Martí S, Ardanuy C, Liñares J, Santos S, Dorca J, García-Nuñez M, Quero S, Monsó E.

Int J Chron Obstruct Pulmon Dis. 2017 Sep 30;12:2807-2811. doi: 10.2147/COPD.S141701. eCollection 2017.

9.

QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.

Muñoz L, Gonzalez L, Soldevila L, Dorca J, Alcaide F, Santin M.

PLoS One. 2017 Aug 30;12(8):e0183258. doi: 10.1371/journal.pone.0183258. eCollection 2017.

10.

Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study.

Huertas D, Montón C, Marín A, Solanes I, López-Sánchez M, Pomares X, Muñoz-Esquerre M, Dorca J, Santos S.

COPD. 2017 Jun;14(3):304-310. doi: 10.1080/15412555.2017.1279598. Epub 2017 Feb 10.

PMID:
28548631
11.

Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).

Muñoz-Esquerre M, Aliagas E, López-Sánchez M, Escobar I, Huertas D, Penín R, Dorca J, Santos S.

PLoS One. 2017 May 18;12(5):e0177218. doi: 10.1371/journal.pone.0177218. eCollection 2017.

12.

The microbiome in respiratory medicine: current challenges and future perspectives.

Faner R, Sibila O, Agustí A, Bernasconi E, Chalmers JD, Huffnagle GB, Manichanh C, Molyneaux PL, Paredes R, Pérez Brocal V, Ponomarenko J, Sethi S, Dorca J, Monsó E.

Eur Respir J. 2017 Apr 12;49(4). pii: 1602086. doi: 10.1183/13993003.02086-2016. Print 2017 Apr. Review.

13.

Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994-2015.

Alcaide F, Peña MJ, Pérez-Risco D, Camprubi D, Gonzalez-Luquero L, Grijota-Camino MD, Dorca J, Santin M.

Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1425-1432. doi: 10.1007/s10096-017-2949-0. Epub 2017 Mar 20.

PMID:
28321580
14.

Successful Healing of Tracheal Radionecrosis: Role of Hyperbaric Oxygen Therapy.

Ariza-Prota M, Morales A, Grajeda J, López-Lisbona R, Cubero N, Dorca J, Rosell A.

Chest. 2016 Dec;150(6):e147-e150. doi: 10.1016/j.chest.2016.03.027.

PMID:
27938770
15.

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.

Machahua C, Montes-Worboys A, Llatjos R, Escobar I, Dorca J, Molina-Molina M, Vicens-Zygmunt V.

Respir Res. 2016 Nov 5;17(1):144.

16.

Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.

Viasus D, Simonetti AF, Garcia-Vidal C, Niubó J, Dorca J, Carratalà J.

J Antimicrob Chemother. 2017 Feb;72(2):547-553. doi: 10.1093/jac/dkw441. Epub 2016 Oct 20.

PMID:
27798219
17.

Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD study.

Vogelmeier C, Paggiaro PL, Dorca J, Sliwinski P, Mallet M, Kirsten AM, Beier J, Seoane B, Segarra RM, Leselbaum A.

Eur Respir J. 2016 Oct;48(4):1030-1039. doi: 10.1183/13993003.00216-2016. Epub 2016 Aug 4.

18.

Dendriform Pulmonary Ossification in a Subclinical Case of Familial Pulmonary Fibrosis.

Diez-Ferrer M, Luburich P, Llatjós R, Xaubet A, Dorca J, Molina-Molina M.

Arch Bronconeumol. 2016 Dec;52(12):e9-e10. doi: 10.1016/j.arbres.2016.05.009. Epub 2016 Jul 5. English, Spanish. No abstract available.

19.

[Lymphoproliferative pulmonary infiltration: A diagnosis to keep in mind in pulmonary infiltrates in patient with chronic lymphocytic leukemia].

González-Fernández C, Dorca J, Molina-Molina M.

Med Clin (Barc). 2016 Sep 2;147(5):224-225. doi: 10.1016/j.medcli.2016.03.024. Epub 2016 May 12. Spanish. No abstract available.

PMID:
27181216
20.

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.

Muñoz-Esquerre M, López-Sánchez M, Escobar I, Huertas D, Penín R, Molina-Molina M, Manresa F, Dorca J, Santos S.

PLoS One. 2016 Apr 5;11(4):e0152987. doi: 10.1371/journal.pone.0152987. eCollection 2016.

21.

Declining mortality among hospitalized patients with community-acquired pneumonia.

Simonetti AF, Garcia-Vidal C, Viasus D, García-Somoza D, Dorca J, Gudiol F, Carratalà J.

Clin Microbiol Infect. 2016 Jun;22(6):567.e1-7. doi: 10.1016/j.cmi.2016.03.015. Epub 2016 Mar 26.

22.

Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patients.

Rosell A, Rodríguez N, Monsó E, Taron M, Millares L, Ramírez JL, López-Lisbona R, Cubero N, Andreo F, Sanz J, Llatjós M, Llatjós R, Fernández-Figueras MT, Mate JL, Català I, Setó L, Roset M, Díez-Ferrer M, Dorca J.

Lung Cancer. 2016 Apr;94:102-7. doi: 10.1016/j.lungcan.2016.02.003. Epub 2016 Feb 11.

PMID:
26973214
23.

Colchicine Treatment for Tracheobronchial Amyloidosis.

Morales A, Pari M, López-Lisbona R, Cubero N, Dorca J, Rosell A.

Respiration. 2016;91(3):251-5. doi: 10.1159/000443669. Epub 2016 Feb 9.

24.

Preclinical lung disease in early rheumatoid arthritis.

Robles-Perez A, Luburich P, Rodriguez-Sanchon B, Dorca J, Nolla JM, Molina-Molina M, Narvaez-Garcia J.

Chron Respir Dis. 2016 Feb;13(1):75-81. doi: 10.1177/1479972315620746.

25.

Transcutaneous Carbon Dioxide Monitoring in Subjects With Acute Respiratory Failure and Severe Hypercapnia.

Ruiz Y, Farrero E, Córdoba A, González N, Dorca J, Prats E.

Respir Care. 2016 Apr;61(4):428-33. doi: 10.4187/respcare.04283. Epub 2016 Jan 19.

26.

Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction.

López-Sánchez M, Muñoz-Esquerre M, Huertas D, Montes A, Molina-Molina M, Manresa F, Dorca J, Santos S.

Clin Respir J. 2017 Nov;11(6):859-866. doi: 10.1111/crj.12428. Epub 2016 Jan 6.

PMID:
26663885
27.

Combined Bronchial Artery Embolization and Endobronchial Resection for Bronchial Carcinoid: A Safety and Feasibility Pilot Study.

Salamonsen M, Tazi-Mezalek R, López-Lisbona R, Cubero N, Baixeras N, Dominguez J, Dorca J, Rosell A.

Respiration. 2016;91(1):63-8. doi: 10.1159/000442487. Epub 2015 Dec 3.

28.

Erratum to: Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.

Vicens-Zygmunt V, Estany S, Colom A, Montes-Worboys A, Machahua C, Sanabria AJ, Llatjos R, Escobar I, Manresa F, Dorca J, Navajas D, Alcaraz J, Molina-Molina M.

Respir Res. 2015 Nov 2;16:136. doi: 10.1186/s12931-015-0277-4. No abstract available.

29.

Transarterial EBUS-TBNA in the Diagnosis of Hilar Lesions.

Cubero N, Salamonsen M, López-Lisbona R, Dorca J, Rosell A.

J Bronchology Interv Pulmonol. 2015 Oct;22(4):e19-22. doi: 10.1097/LBR.0000000000000215. Review. No abstract available.

PMID:
26492614
30.

Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.

Martin-Castillo B, Lopez-Bonet E, Cuyàs E, Viñas G, Pernas S, Dorca J, Menendez JA.

Oncotarget. 2015 Oct 20;6(32):32317-38. doi: 10.18632/oncotarget.6094.

31.

Impact of an Educational Program to Reduce Healthcare Resources in Community-Acquired Pneumonia: The EDUCAP Randomized Controlled Trial.

Adamuz J, Viasus D, Simonetti A, Jiménez-Martínez E, Molero L, González-Samartino M, Castillo E, Juvé-Udina ME, Alcocer MJ, Hernández C, Buera MP, Roel A, Abad E, Zabalegui A, Ricart P, Gonzalez A, Isla P, Dorca J, Garcia-Vidal C, Carratalà J.

PLoS One. 2015 Oct 13;10(10):e0140202. doi: 10.1371/journal.pone.0140202. eCollection 2015.

32.

Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.

Vicens-Zygmunt V, Estany S, Colom A, Montes-Worboys A, Machahua C, Sanabria AJ, Llatjos R, Escobar I, Manresa F, Dorca J, Navajas D, Alcaraz J, Molina-Molina M.

Respir Res. 2015 Jul 1;16:82. doi: 10.1186/s12931-015-0237-z. Erratum in: Respir Res. 2015;16:136.

33.

Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients.

Muñoz-Esquerre M, Huertas D, Escobar I, López-Sánchez M, Penín R, Peinado V, Barberà JA, Molina-Molina M, Manresa F, Dorca J, Santos S.

Lung. 2015 Jun;193(3):335-43. doi: 10.1007/s00408-015-9717-7. Epub 2015 Mar 21.

PMID:
25794567
34.

Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant basal-HER2 subtype of breast cancer.

Martin-Castillo B, Lopez-Bonet E, Buxó M, Dorca J, Tuca-Rodríguez F, Ruano MA, Colomer R, Menendez JA.

Oncotarget. 2015 Mar 30;6(9):7104-22.

35.

The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.

Viasus D, Garcia-Vidal C, Simonetti AF, Dorca J, Llopis F, Mestre M, Morandeira-Rego F, Carratalà J.

BMJ Open. 2015 Jan 6;5(1):e006251. doi: 10.1136/bmjopen-2014-006251.

36.

Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Agustí A, Antó JM, Auffray C, Barbé F, Barreiro E, Dorca J, Escarrabill J, Faner R, Furlong LI, Garcia-Aymerich J, Gea J, Lindmark B, Monsó E, Plaza V, Puhan MA, Roca J, Ruiz-Manzano J, Sampietro-Colom L, Sanz F, Serrano L, Sharpe J, Sibila O, Silverman EK, Sterk PJ, Sznajder JI.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):391-401. doi: 10.1164/rccm.201410-1935PP.

37.

Roflumilast added to triple therapy in patients with severe COPD: a real life study.

Muñoz-Esquerre M, Diez-Ferrer M, Montón C, Pomares X, López-Sánchez M, Huertas D, Manresa F, Dorca J, Santos S.

Pulm Pharmacol Ther. 2015 Feb;30:16-21. doi: 10.1016/j.pupt.2014.10.002. Epub 2014 Oct 30.

PMID:
25445930
38.

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).

Aparicio J, Maroto P, García del Muro X, Sánchez-Muñoz A, Gumà J, Margelí M, Sáenz A, Sagastibelza N, Castellano D, Arranz JA, Hervás D, Bastús R, Fernández-Aramburo A, Sastre J, Terrasa J, López-Brea M, Dorca J, Almenar D, Carles J, Hernández A, Germà JR.

Ann Oncol. 2014 Nov;25(11):2173-8. doi: 10.1093/annonc/mdu437. Epub 2014 Sep 10.

PMID:
25210015
39.

Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.

Gómez-Junyent J, Garcia-Vidal C, Viasus D, Millat-Martínez P, Simonetti A, Santos MS, Ardanuy C, Dorca J, Carratalà J.

PLoS One. 2014 Aug 28;9(8):e105854. doi: 10.1371/journal.pone.0105854. eCollection 2014.

40.

Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.

Estany S, Vicens-Zygmunt V, Llatjós R, Montes A, Penín R, Escobar I, Xaubet A, Santos S, Manresa F, Dorca J, Molina-Molina M.

BMC Pulm Med. 2014 Jul 26;14:120. doi: 10.1186/1471-2466-14-120.

41.

Impact of pre-hospital antibiotic use on community-acquired pneumonia.

Simonetti AF, Viasus D, Garcia-Vidal C, Grillo S, Molero L, Dorca J, Carratalà J.

Clin Microbiol Infect. 2014 Sep;20(9):O531-7. doi: 10.1111/1469-0691.12524. Epub 2014 Feb 10.

42.

Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia.

Adamuz J, Viasus D, Jiménez-Martínez E, Isla P, Garcia-Vidal C, Dorca J, Carratalà J.

J Infect. 2014 Jun;68(6):534-41. doi: 10.1016/j.jinf.2014.02.006. Epub 2014 Feb 15.

PMID:
24534605
43.

Infectious etiology of acute exacerbations in severe COPD patients.

Domenech A, Puig C, Martí S, Santos S, Fernández A, Calatayud L, Dorca J, Ardanuy C, Liñares J.

J Infect. 2013 Dec;67(6):516-23. doi: 10.1016/j.jinf.2013.09.003. Epub 2013 Sep 20.

PMID:
24055804
44.

Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin.

Cufí S, Corominas-Faja B, Lopez-Bonet E, Bonavia R, Pernas S, López IÁ, Dorca J, Martínez S, López NB, Fernández SD, Cuyàs E, Visa J, Rodríguez-Gallego E, Quirantes-Piné R, Segura-Carretero A, Joven J, Martin-Castillo B, Menendez JA.

Oncotarget. 2013 Sep;4(9):1484-95.

45.

Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients.

Porta R, Blancafort A, Casòliva G, Casas M, Dorca J, Buxo M, Viñas G, Oliveras G, Puig T.

Menopause. 2014 Feb;21(2):188-91. doi: 10.1097/GME.0b013e31829d17dc.

PMID:
23982110
46.

High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study.

López-Sánchez M, Muñoz-Esquerre M, Huertas D, Gonzalez-Costello J, Ribas J, Manresa F, Dorca J, Santos S.

PLoS One. 2013 Jun 27;8(6):e68034. doi: 10.1371/journal.pone.0068034. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/b4120833-e4c6-42b5-92e9-24c396f9444e.

47.

Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia.

Garcia-Vidal C, Labori M, Viasus D, Simonetti A, Garcia-Somoza D, Dorca J, Gudiol F, Carratalà J.

PLoS One. 2013 Apr 16;8(4):e61036. doi: 10.1371/journal.pone.0061036. Print 2013.

48.

Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia.

Viasus D, Garcia-Vidal C, Simonetti A, Manresa F, Dorca J, Gudiol F, Carratalà J.

J Infect. 2013 May;66(5):415-23. doi: 10.1016/j.jinf.2012.12.007. Epub 2012 Dec 31.

PMID:
23286966
49.

Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.

Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J.

Medicine (Baltimore). 2013 Jan;92(1):51-60. doi: 10.1097/MD.0b013e31827f6104.

50.

Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus.

Di Yacovo S, Garcia-Vidal C, Viasus D, Adamuz J, Oriol I, Gili F, Vilarrasa N, García-Somoza MD, Dorca J, Carratalà J.

Medicine (Baltimore). 2013 Jan;92(1):42-50. doi: 10.1097/MD.0b013e31827f602a.

Supplemental Content

Support Center